|
May 14
|
Bio-Techne Corporation (TECH) Declined on Weak Q4 Results
|
|
May 9
|
Bio-Techne Third Quarter 2024 Earnings: Beats Expectations
|
|
May 8
|
5 Stocks at the Forefront of S&P 500 ETF's Latest Rally
|
|
May 8
|
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
|
|
May 7
|
BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
|
|
May 4
|
Bio-Techne Corporation Just Recorded A 7.6% EPS Beat: Here's What Analysts Are Forecasting Next
|
|
May 2
|
Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript
|
|
May 2
|
Bio-Techne Corp (TECH) (Q3 2024) Earnings Call Transcript Highlights: Navigating Market ...
|
|
May 1
|
Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Here’s Why.
|
|
May 1
|
Bio-Techne Corporation (NASDAQ:TECH) Shares Could Be 25% Above Their Intrinsic Value Estimate
|
|
May 1
|
Bio-Techne Corp (TECH) Q3 Fiscal 2024 Earnings: Mixed Results Amid Market Challenges
|
|
May 1
|
Bio-Techne beats third-quarter estimates on improving demand for biotech products
|
|
May 1
|
BIO-TECHNE DECLARES DIVIDEND
|
|
May 1
|
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
|
|
Apr 30
|
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
|
|
Apr 29
|
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
|
|
Apr 26
|
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
|
|
Apr 23
|
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
|
|
Apr 10
|
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
|
|
Apr 8
|
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
|